SO
SOPHiA GENETICS S.A.
SOPH · NASDAQ
$8.19 -4.32% (-$0.37)
1M -3.08%
Market Cap $687.1M
P/E Ratio -
Div. Yield -
ROE 136.71%
Bulios Fair Price
$9.94
21.4% upside
Trenutna cena
$8.19
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SOPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
3 /100
Expensive P/S 7.97x
P/B 8.27x
P/E N/A
Growth
76 /100
Growing Rev. growth 17.56%
Book val. growth 38.24%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 66.63%
Net margin 93.86%
Op. margin 85.01%
Quality
5 /100
Poor ROIC 49.18%
ROE 136.71%
ROA 40.77%
Debt
54 /100
Moderate Debt/Equity 0.74x
Current ratio 2.69x
Int. coverage -11.22x
Stability
70 /100
Stable Beta 0.98x
Rev. volatility 13.33%
EPS volatility 23.49%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SOPH
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ross Muken
Employees
415
Headquarters
Rolle
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report